TELO
TelomirยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TELO Profile
Telomir Pharmaceuticals, Inc.
A preclinical stage biotechnology company
100 SE 2nd St, Suite 200 #1009, Miami, Florida 33131
--
Telomir Pharmaceuticals, Inc., was incorporated as a Florida company in August 2021. The company is a preclinical stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule under development for oral in situ therapeutic therapy of human stem cells. In situ stem cell therapy uses the body's natural resources to regenerate damaged tissue and replace cells with new functional cells.
